Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by VERSCHURE, P. J.
Right arrow Articles by VAN DEN BERG, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VERSCHURE, P. J.
Right arrow Articles by VAN DEN BERG, W. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 British Society for Rheumatology


research-article

LOCALIZATION OF INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR IN HUMAN NORMAL AND OSTEOARTHRITIC CARTILAGE IN RELATION TO PROTEOGLYCAN SYNTHESIS AND CONTENT

P. J. VERSCHURE, J. VAN MARLE*, L. A. B. JOOSTEN, M. M. A. HELSEN, F. P. J. G. LAFEBER{dagger} and W. B. VAN DEN BERG

Department of Rheumatology, University Hospital Nijmegen Geert Grooteplein Zuid 8, 6525 GA Nijmegen
*Academic Medical Center, University of Amsterdam, Department of Electron Microscopy PO Box 22700, 1100 DE Amsterdam
{dagger}Department of Rheumatology, University Hospital Utrecht PO Box 85500, 3508 GA Utrecht, The Netherlands

Correspondence to: Correspondence to: P. J. Verschure, Department of Rheumatology, University Hospital, Geert Grooteplein Zuid 8, 6525 GA Nijmegen, The Netherlands.

Insulin-like growth factor-1 (IGF-1) plays a key role in the regulation of chondrocyte proteoglycan (PG) metabolism. We investigated whether chondrocyte PG synthetic activity correlates with the presence of chondrocyte IGF-1 receptor in the surface, middle and deeper zones of normal human articular cartilage and in cartilage known to display a shift in chondrocyte metabolism, i.e. cultured cartilage or osteoarthritic (OA) cartilage. Cartilage specimens were obtained post mortem from human knees within 18 h after death from donors without known clinical OA history. The samples were taken from macroscopically normal looking regions as well as from damaged regions with osteoarthritic appearance, yielding a range of OA grades from mild to moderate and severe OA. We examined chondrocyte PG synthesis by in situ autoradiography of incorporated [35S]sulphate and chondrocyte IGF-1 receptor localization by immunohistochemistry, followed by confocal laser scanning microscopical (CLSM) analysis in the same cartilage samples. In normal cartilage, both the amount of chondrocyte PG synthesis and the level of chondrocyte IGF-1 receptor localization are at low levels in the surface zone chondrocytes, but both are high in middle and deeper zone chondrocytes. Furthermore, after culture, the increase in chondrocyte PG synthesis in the surface layer coincides with increase in IGF-1 receptor expression. However, in mild OA particularly high levels of chondrocyte synthetic activity were found in the upper cartilage layer, whereas IGF-1 receptor expression was low in this layer, suggesting that factors other than IGF-1 are involved. High chondrocyte PG synthetic activity and chondrocyte IGF-1 receptor staining were found in the upper and deeper layers of moderate OA cartilage, whereas both low levels of chondrocyte activity as well as IGF-1 receptors were observed in cases of severe OA. Our data indicate that IGF-1 displays cellular heterogeneity in chondrocyte stimulation in the various cartilage zones in normal cartilage. Gear zonal correlation is lost in OA cartilage, and patterns of chondrocyte IGF-1 receptor expression and PG synthesis vary with the stage of OA.

KEY WORDS: Chondrocyte, Cartilage, OA, IGF-1 receptor, PG synthesis, In situ, CLSM, Zonal analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
G. Verbruggen
Chondroprotective drugs in degenerative joint diseases
Rheumatology, February 1, 2006; 45(2): 129 - 138.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Okazaki, S. Jingushi, T. Ikenoue, K. Urabe, H. Sakai, A. Ohtsuru, K. Akino, S. Yamashita, S. Nomura, and Y. Iwamoto
Expression of Insulin-Like Growth Factor I Messenger Ribonucleic Acid in Developing Osteophytes in Murine Experimental Osteoarthritis and in Rats Inoculated with Growth Hormone-Secreting Tumor
Endocrinology, October 1, 1999; 140(10): 4821 - 4830.
[Abstract] [Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.